- Home
- REAL vs PRAX Comparison
REAL vs PRAX Comparison
Compare REAL & PRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REAL
- PRAX
- Stock Information
- Founded
- REAL 2011
- PRAX 2015
- Country
- REAL United States
- PRAX United States
- Employees
- REAL N/A
- PRAX N/A
- Industry
- REAL Other Specialty Stores
- PRAX Biotechnology: Pharmaceutical Preparations
- Sector
- REAL Consumer Discretionary
- PRAX Health Care
- Exchange
- REAL Nasdaq
- PRAX Nasdaq
- Market Cap
- REAL 1.2B
- PRAX 1.4B
- IPO Year
- REAL 2019
- PRAX 2020
- Fundamental
- Price
- REAL $9.15
- PRAX $83.01
- Analyst Decision
- REAL Buy
- PRAX Strong Buy
- Analyst Count
- REAL 6
- PRAX 9
- Target Price
- REAL $7.04
- PRAX $149.11
- AVG Volume (30 Days)
- REAL 2.9M
- PRAX 350.3K
- Earning Date
- REAL 02-27-2025
- PRAX 03-04-2025
- Dividend Yield
- REAL N/A
- PRAX N/A
- EPS Growth
- REAL N/A
- PRAX N/A
- EPS
- REAL N/A
- PRAX N/A
- Revenue
- REAL $579,862,000.00
- PRAX $1,605,000.00
- Revenue This Year
- REAL $11.27
- PRAX N/A
- Revenue Next Year
- REAL $9.11
- PRAX N/A
- P/E Ratio
- REAL N/A
- PRAX N/A
- Revenue Growth
- REAL 2.52
- PRAX N/A
- 52 Week Low
- REAL $1.52
- PRAX $33.01
- 52 Week High
- REAL $11.38
- PRAX $86.93
- Technical
- Relative Strength Index (RSI)
- REAL 50.80
- PRAX 62.96
- Support Level
- REAL $8.65
- PRAX $73.50
- Resistance Level
- REAL $10.14
- PRAX $83.24
- Average True Range (ATR)
- REAL 0.54
- PRAX 4.30
- MACD
- REAL -0.11
- PRAX 0.89
- Stochastic Oscillator
- REAL 33.56
- PRAX 94.95
About REAL The RealReal Inc.
The RealReal is the largest pure-play luxury resale platform in the us, generating $1.7 billion in 2023 gross merchandise volume and addressing a niche (personal luxury resale) that had previously been serviced by inefficient upscale boutiques and local pawn shops. The company generates revenue via consignment and first-party sales on its online marketplace, and through a small volume of direct sales. With a hands-on approach that actively sources inventory and authenticates every item on its platform, The RealReal is able to justify much higher take rates than peers, working out to roughly 34% of net merchandise value, which excludes returns, cancellations, and first-party sales.
About PRAX Praxis Precision Medicines Inc.
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The firm's pipeline covers PRAX-114, for the treatment of a broad range of patients suffering from major depressive disorder and post-traumatic stress disorder; PRAX-944, for the treatment of Essential Tremor and Parkinson's Disease; PRAX-562, and PRAX-222, among others.